Where is L-DOPA decarboxylated in the striatum after 6-hydroxydopamine nigrotomy?
D000818:Animals; D001545:Benserazide / Q000008:administration & dosage; D001812:Blood-Brain Barrier; D002196:Capillaries / Q000378:metabolism; D003342:Corpus Striatum / Q000098:blood supply / Q000378:metabolism*; D003653:Decarboxylation; D004298:Dopamine / Q000378:metabolism; D004727:Endothelium / Q000378:metabolism; D005260:Female; D006801:Humans; D006892:Hydroxydopamines / Q000633:toxicity*; D007980:Levodopa / Q000008:administration & dosage / Q000378:metabolism*; D008750:Methyldopa / Q000008:administration & dosage; D011292:Premedication; D051381:Rats; D011954:Receptors, Dopamine / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects*
D006892:Hydroxydopamines; D011954:Receptors, Dopamine; D007980:Levodopa; D008750:Methyldopa; D001545:Benserazide; D004298:Dopamine